
PMC:7594251 / 94313-95568
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T197 | 175-182 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T198 | 252-262 | Body_part | denotes | amino acid | http://purl.org/sig/ont/fma/fma82739 |
T199 | 347-357 | Body_part | denotes | amino acid | http://purl.org/sig/ont/fma/fma82739 |
T200 | 433-440 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T201 | 483-490 | Body_part | denotes | protein | http://purl.org/sig/ont/fma/fma67257 |
T202 | 748-759 | Body_part | denotes | amino acids | http://purl.org/sig/ont/fma/fma82739 |
T203 | 944-955 | Body_part | denotes | amino acids | http://purl.org/sig/ont/fma/fma82739 |
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T107 | 94-97 | Disease | denotes | SOS | http://purl.obolibrary.org/obo/MONDO_0011604 |
T108 | 114-117 | Disease | denotes | STD | http://purl.obolibrary.org/obo/MONDO_0021681 |
T109 | 301-304 | Disease | denotes | SOS | http://purl.obolibrary.org/obo/MONDO_0011604 |
T110 | 1046-1049 | Disease | denotes | SOS | http://purl.obolibrary.org/obo/MONDO_0011604 |
T111 | 1148-1151 | Disease | denotes | SOS | http://purl.obolibrary.org/obo/MONDO_0011604 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T665 | 0-1 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | A |
T666 | 84-92 | http://purl.obolibrary.org/obo/CLO_0007225 | denotes | labeling |
T667 | 233-234 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T668 | 521-524 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
T669 | 772-775 | http://purl.obolibrary.org/obo/CLO_0037067 | denotes | Val |
T670 | 1213-1214 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T570 | 143-149 | Chemical | denotes | ligand | http://purl.obolibrary.org/obo/CHEBI_52214 |
T571 | 175-182 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T572 | 252-262 | Chemical | denotes | amino acid | http://purl.obolibrary.org/obo/CHEBI_33709 |
T573 | 252-257 | Chemical | denotes | amino | http://purl.obolibrary.org/obo/CHEBI_46882 |
T574 | 258-262 | Chemical | denotes | acid | http://purl.obolibrary.org/obo/CHEBI_37527 |
T575 | 332-338 | Chemical | denotes | ligand | http://purl.obolibrary.org/obo/CHEBI_52214 |
T576 | 347-357 | Chemical | denotes | amino acid | http://purl.obolibrary.org/obo/CHEBI_33709 |
T577 | 347-352 | Chemical | denotes | amino | http://purl.obolibrary.org/obo/CHEBI_46882 |
T578 | 353-357 | Chemical | denotes | acid | http://purl.obolibrary.org/obo/CHEBI_37527 |
T579 | 433-440 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T580 | 483-490 | Chemical | denotes | protein | http://purl.obolibrary.org/obo/CHEBI_36080 |
T581 | 491-497 | Chemical | denotes | ligand | http://purl.obolibrary.org/obo/CHEBI_52214 |
T582 | 596-609 | Chemical | denotes | benzimidazole | http://purl.obolibrary.org/obo/CHEBI_36622|http://purl.obolibrary.org/obo/CHEBI_41275 |
T584 | 632-639 | Chemical | denotes | uridine | http://purl.obolibrary.org/obo/CHEBI_16704 |
T585 | 672-682 | Chemical | denotes | UDP-GlcNAc | http://purl.obolibrary.org/obo/CHEBI_16264 |
T586 | 672-675 | Chemical | denotes | UDP | http://purl.obolibrary.org/obo/CHEBI_17659|http://purl.obolibrary.org/obo/CHEBI_58223 |
T588 | 676-682 | Chemical | denotes | GlcNAc | http://purl.obolibrary.org/obo/CHEBI_506227|http://purl.obolibrary.org/obo/CHEBI_73685 |
T590 | 748-759 | Chemical | denotes | amino acids | http://purl.obolibrary.org/obo/CHEBI_33709 |
T591 | 748-753 | Chemical | denotes | amino | http://purl.obolibrary.org/obo/CHEBI_46882 |
T592 | 754-759 | Chemical | denotes | acids | http://purl.obolibrary.org/obo/CHEBI_37527 |
T593 | 767-770 | Chemical | denotes | Ile | http://purl.obolibrary.org/obo/CHEBI_17191|http://purl.obolibrary.org/obo/CHEBI_30009 |
T595 | 772-775 | Chemical | denotes | Val | http://purl.obolibrary.org/obo/CHEBI_16414|http://purl.obolibrary.org/obo/CHEBI_30015 |
T597 | 777-780 | Chemical | denotes | Leu | http://purl.obolibrary.org/obo/CHEBI_15603|http://purl.obolibrary.org/obo/CHEBI_25017|http://purl.obolibrary.org/obo/CHEBI_30006 |
T600 | 782-785 | Chemical | denotes | Met | http://purl.obolibrary.org/obo/CHEBI_16044|http://purl.obolibrary.org/obo/CHEBI_16643|http://purl.obolibrary.org/obo/CHEBI_16811 |
T603 | 793-796 | Chemical | denotes | Trp | http://purl.obolibrary.org/obo/CHEBI_16828|http://purl.obolibrary.org/obo/CHEBI_27897|http://purl.obolibrary.org/obo/CHEBI_29954 |
T606 | 798-801 | Chemical | denotes | Phe | http://purl.obolibrary.org/obo/CHEBI_17295|http://purl.obolibrary.org/obo/CHEBI_29997 |
T608 | 891-897 | Chemical | denotes | ligand | http://purl.obolibrary.org/obo/CHEBI_52214 |
T609 | 944-955 | Chemical | denotes | amino acids | http://purl.obolibrary.org/obo/CHEBI_33709 |
T610 | 944-949 | Chemical | denotes | amino | http://purl.obolibrary.org/obo/CHEBI_46882 |
T611 | 950-955 | Chemical | denotes | acids | http://purl.obolibrary.org/obo/CHEBI_37527 |
T612 | 1001-1007 | Chemical | denotes | ligand | http://purl.obolibrary.org/obo/CHEBI_52214 |
T613 | 1098-1102 | Chemical | denotes | drug | http://purl.obolibrary.org/obo/CHEBI_23888 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
979 | 581-609 | Chemical | denotes | 2-(3′-pyridyl)-benzimidazole | |
980 | 632-670 | Chemical | denotes | uridine diphosphateN-acetylglucosamine | |
981 | 672-682 | Chemical | denotes | UDP-GlcNAc | |
982 | 767-770 | Chemical | denotes | Ile | MESH:D007532 |
983 | 772-775 | Chemical | denotes | Val | MESH:D014633 |
984 | 777-780 | Chemical | denotes | Leu | MESH:D007930 |
985 | 793-796 | Chemical | denotes | Trp | MESH:D014364 |
986 | 798-801 | Chemical | denotes | Phe | MESH:D010649 |
987 | 803-806 | Chemical | denotes | His | MESH:D006639 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T614 | 0-263 | Sentence | denotes | A third method called structural information using Overhauser effects and selective labeling (SOS-NMR), relies of STD experiments performed on ligand complexes with different protein samples that have been fully deuterated excluding a specific type of amino acid. |
T615 | 264-506 | Sentence | denotes | In other words, the data obtained by SOS-NMR gives insight into the ligand-binding amino acid composition and when taken into consideration the 3D structure of targeted protein can be used to establish the structure of protein-ligand complex. |
T616 | 507-684 | Sentence | denotes | This approach has been demonstrated using two complexes—FKBP complexed to 2-(3′-pyridyl)-benzimidazole and MurA complexed to uridine diphosphateN-acetylglucosamine (UDP-GlcNAc). |
T617 | 685-766 | Sentence | denotes | The results showed that for FKBP and MurA, only four and three amino acids (FKBP: |
T618 | 767-792 | Sentence | denotes | Ile, Val, Leu, Met; MurA: |
T619 | 793-911 | Sentence | denotes | Trp, Phe, His) were needed to be selectively protonated in perdeuterated samples to establish the ligand-binding site. |
T620 | 912-1024 | Sentence | denotes | Additionally, on average only 6 amino acids were required for accurate identification of ligand-binding surface. |
T621 | 1025-1127 | Sentence | denotes | According to authors SOS-NMR can greatly improve the early stages of the drug discovery process [397]. |
T622 | 1128-1255 | Sentence | denotes | Moreover, combining SOS-NMR with other methods can even further increase chances for a positive outcome of an experiment [398]. |